Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature

The molecular biology of metastatic potential in melanoma has been studied many times previously and changes in the expression of many genes have been linked to metastatic behaviour. What is lacking is a systematic characterization of the regulatory relationships between genes whose expression is re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hoek, Keith (VerfasserIn) , Sucker, Antje (VerfasserIn) , Ugurel, Selma (VerfasserIn) , Kumar, Rajiv (VerfasserIn) , Schadendorf, Dirk (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 23 June 2006
In: Pigment cell research
Year: 2006, Jahrgang: 19, Heft: 4, Pages: 290-302
ISSN:1600-0749
DOI:https://doi.org/10.1111/j.1600-0749.2006.00322.x
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/https://doi.org/10.1111/j.1600-0749.2006.00322.x
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1600-0749.2006.00322.x
Volltext
Verfasserangaben:Keith S. Hoek, Natalie C. Schlegel, Patricia Brafford, Antje Sucker, Selma Ugurel, Rajiv Kumar, Barbara L. Weber, Katherine L. Nathanson, David J. Phillips, Meenhard Herlyn, Dirk Schadendorf and Reinhard Dummer

MARC

LEADER 00000caa a2200000 c 4500
001 1747881724
003 DE-627
005 20220819101636.0
007 cr uuu---uuuuu
008 210209s2006 xx |||||o 00| ||eng c
024 7 |a 10.1111/j.1600-0749.2006.00322.x  |2 doi 
035 |a (DE-627)1747881724 
035 |a (DE-599)KXP1747881724 
035 |a (OCoLC)1341391932 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hoek, Keith  |e VerfasserIn  |0 (DE-588)1226806171  |0 (DE-627)1747882399  |4 aut 
245 1 0 |a Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature  |c Keith S. Hoek, Natalie C. Schlegel, Patricia Brafford, Antje Sucker, Selma Ugurel, Rajiv Kumar, Barbara L. Weber, Katherine L. Nathanson, David J. Phillips, Meenhard Herlyn, Dirk Schadendorf and Reinhard Dummer 
264 1 |c 23 June 2006 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.02.2021 
520 |a The molecular biology of metastatic potential in melanoma has been studied many times previously and changes in the expression of many genes have been linked to metastatic behaviour. What is lacking is a systematic characterization of the regulatory relationships between genes whose expression is related to metastatic potential. Such a characterization would produce a molecular taxonomy for melanoma which could feasibly be used to identify epigenetic mechanisms behind changes in metastatic behaviour. To achieve this we carried out three separate DNA microarray analyses on a total of 86 cultures of melanoma. Significantly, multiple testing correction revealed that previous reports describing correlations of gene expression with activating mutations in BRAF or NRAS were incorrect and that no gene expression patterns correlate with the mutation status of these MAPK pathway components. Instead, we identified three different sample cohorts (A, B and C) and found that these cohorts represent melanoma groups of differing metastatic potential. Cohorts A and B were susceptible to transforming growth factor-β (TGFβ)-mediated inhibition of proliferation and had low motility. Cohort C was resistant to TGFβ and demonstrated high motility. Meta-analysis of the data against previous studies linking gene expression and phenotype confirmed that cohorts A and C represent transcription signatures of weakly and strongly metastatic melanomas, respectively. Gene expression co-regulation suggested that signalling via TGFβ-type and Wnt/β-catenin pathways underwent considerable change between cohorts. These results suggest a model for the transition from weakly to strongly metastatic melanomas in which TGFβ-type signalling upregulates genes expressing vasculogenic/extracellular matrix remodelling factors and Wnt signal inhibitors, coinciding with a downregulation of genes downstream of Wnt signalling. 
650 4 |a BRAF 
650 4 |a gene expression 
650 4 |a melanoma 
650 4 |a metastatic potential 
700 1 |a Sucker, Antje  |e VerfasserIn  |0 (DE-588)1161138153  |0 (DE-627)1024540596  |0 (DE-576)506375412  |4 aut 
700 1 |a Ugurel, Selma  |d 1971-  |e VerfasserIn  |0 (DE-588)122030923  |0 (DE-627)081693532  |0 (DE-576)293057567  |4 aut 
700 1 |a Kumar, Rajiv  |d 1955-  |e VerfasserIn  |0 (DE-588)1164253425  |0 (DE-627)1028811942  |0 (DE-576)508469805  |4 aut 
700 1 |a Schadendorf, Dirk  |d 1960-  |e VerfasserIn  |0 (DE-588)11142576X  |0 (DE-627)499566076  |0 (DE-576)289702275  |4 aut 
773 0 8 |i Enthalten in  |t Pigment cell research  |d Oxford [u.a.] : Blackwell, 1987  |g 19(2006), 4, Seite 290-302  |h Online-Ressource  |w (DE-627)324456026  |w (DE-600)2027000-8  |w (DE-576)093888791  |x 1600-0749  |7 nnas  |a Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature 
773 1 8 |g volume:19  |g year:2006  |g number:4  |g pages:290-302  |g extent:13  |a Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature 
856 4 0 |u https://doi.org/https://doi.org/10.1111/j.1600-0749.2006.00322.x  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1600-0749.2006.00322.x  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210209 
993 |a Article 
994 |a 2006 
998 |g 11142576X  |a Schadendorf, Dirk  |m 11142576X:Schadendorf, Dirk  |d 50000  |e 50000PS11142576X  |k 0/50000/  |p 11 
998 |g 1164253425  |a Kumar, Rajiv  |m 1164253425:Kumar, Rajiv  |p 6 
998 |g 122030923  |a Ugurel, Selma  |m 122030923:Ugurel, Selma  |d 60000  |e 60000PU122030923  |k 0/60000/  |p 5 
998 |g 1161138153  |a Sucker, Antje  |m 1161138153:Sucker, Antje  |d 50000  |e 50000PS1161138153  |k 0/50000/  |p 4 
999 |a KXP-PPN1747881724  |e 3850327248 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"23 June 2006","dateIssuedKey":"2006"}],"language":["eng"],"name":{"displayForm":["Keith S. Hoek, Natalie C. Schlegel, Patricia Brafford, Antje Sucker, Selma Ugurel, Rajiv Kumar, Barbara L. Weber, Katherine L. Nathanson, David J. Phillips, Meenhard Herlyn, Dirk Schadendorf and Reinhard Dummer"]},"person":[{"given":"Keith","role":"aut","display":"Hoek, Keith","roleDisplay":"VerfasserIn","family":"Hoek"},{"family":"Sucker","roleDisplay":"VerfasserIn","given":"Antje","role":"aut","display":"Sucker, Antje"},{"display":"Ugurel, Selma","role":"aut","given":"Selma","family":"Ugurel","roleDisplay":"VerfasserIn"},{"family":"Kumar","roleDisplay":"VerfasserIn","given":"Rajiv","display":"Kumar, Rajiv","role":"aut"},{"given":"Dirk","display":"Schadendorf, Dirk","role":"aut","family":"Schadendorf","roleDisplay":"VerfasserIn"}],"physDesc":[{"extent":"13 S."}],"relHost":[{"origin":[{"dateIssuedDisp":"1987-2007","dateIssuedKey":"1987","publisherPlace":"Oxford [u.a.] ; Copenhagen","publisher":"Blackwell ; Munksgaard"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["International Federation of Pigment Cell Societies (IFPCS)"]},"part":{"pages":"290-302","year":"2006","extent":"13","volume":"19","issue":"4","text":"19(2006), 4, Seite 290-302"},"recId":"324456026","id":{"issn":["1600-0749"],"doi":["10.1111/(ISSN)1600-0749"],"eki":["324456026"],"zdb":["2027000-8"]},"title":[{"title":"Pigment cell research","title_sort":"Pigment cell research"}],"disp":"Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signaturePigment cell research","pubHistory":["1.1987 - 20.2007"]}],"recId":"1747881724","id":{"doi":["10.1111/j.1600-0749.2006.00322.x"],"eki":["1747881724"]},"title":[{"title_sort":"Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature","title":"Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature"}],"note":["Gesehen am 09.02.2021"]} 
SRT |a HOEKKEITHSMETASTATIC2320